A cytostatic drug improves control of HIV-1 replication during structured treatment interruptionsFelipe García, José M. Gatell, José M. Miró et al.|AIDS|2003Cited by 51
Effect of TNF-α genetic variants and CCR5Δ32 on the vulnerability to HIV-1 infection and disease progression in Caucasian SpaniardsSergi Veloso, Francesc Vidal, Montserrat Olona et al.|BMC Medical Genetics|2010Cited by 28